Cellebrite DI (CLBT) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

CLBT Stock Forecast


Cellebrite DI (CLBT) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $20.00 and a low of $20.00. This represents a 3.41% increase from the last price of $19.34.

$5 $9 $13 $17 $21 $25 High: $20 Avg: $20 Low: $20 Last Closed Price: $19.34

CLBT Stock Rating


Cellebrite DI stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

CLBT Price Target Upside V Benchmarks


TypeNameUpside
StockCellebrite DI3.41%
SectorTechnology Stocks 33.74%

Price Target Trends


1M3M12M
# Anlaysts--4
Avg Price Target--$19.25
Last Closing Price$19.34$19.34$19.34
Upside/Downside---0.47%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2526---8
Mar, 2526---8
Feb, 2526---8
Jan, 2526---8
Dec, 2426---8
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2024Tomer ZilbermanBank of America Securities$20.00$18.1110.44%3.41%
Sep 25, 2024Jeff Van RheeCraig-Hallum$23.00$16.8736.34%18.92%
Aug 16, 2024Eric MartinuzziLoop Capital Markets$17.00$16.155.26%-12.10%
Aug 16, 2024Tomer ZilbermanBank of America Securities$17.00$14.9613.64%-12.10%
Apr 01, 2024Jeff Van RheeCraig-Hallum$16.00$11.0844.40%-17.27%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jan 22, 2025NeedhamBuyBuyhold
Sep 25, 2024Craig-HallumBuyBuyhold
Sep 23, 2024Cowen & Co.BuyBuyhold
Aug 16, 2024Lake StreetBuyBuyhold
Aug 16, 2024Deutsche BankBuyBuyhold
May 24, 2024Lake StreetBuyBuyhold
May 24, 2024Cowen & Co.BuyBuyhold
Apr 19, 2024Lake StreetBuyinitialise
Apr 01, 2024Craig-HallumBuyBuyhold
Apr 01, 2024Bank of America SecuritiesBuyBuyhold

Financial Forecast


EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$0.50$0.64$-0.43-----
Avg Forecast$0.19$0.66$-0.30$-1.37$0.26$0.34$0.62$0.72
High Forecast$0.19$0.68$-0.29$-1.31$0.26$0.45$0.64$0.75
Low Forecast$0.19$0.65$-0.31$-1.43$0.25$0.28$0.60$0.70
Surprise %163.16%-3.03%43.33%-----

Revenue Forecast

$200M $310M $420M $530M $640M $750M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$246.25M$270.65M$325.11M-----
Avg Forecast$242.50M$271.47M$317.67M$399.39M$465.58M$548.96M$605.80M$685.50M
High Forecast$246.51M$277.42M$320.17M$400.62M$477.28M$551.00M$623.60M$705.64M
Low Forecast$238.82M$267.24M$314.57M$398.55M$455.42M$546.92M$593.71M$671.82M
Surprise %1.55%-0.30%2.34%-----

Net Income Forecast

$-300M $-210M $-120M $-30M $60M $150M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$71.40M$120.81M$-81.10M-----
Avg Forecast$36.14M$126.26M$-57.27M$-260.51M$48.61M$83.60M$118.62M$136.91M
High Forecast$36.92M$129.86M$-54.97M$-248.39M$50.29M$85.57M$122.40M$142.14M
Low Forecast$35.43M$123.71M$-59.56M$-272.62M$46.93M$52.87M$114.84M$133.36M
Surprise %97.54%-4.32%41.62%-----

CLBT Forecast FAQ


Is Cellebrite DI stock a buy?

Cellebrite DI stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cellebrite DI is a favorable investment for most analysts.

What is Cellebrite DI's price target?

Cellebrite DI's price target, set by 8 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $20 at the low end to $20 at the high end, suggesting a potential 3.41% change from the previous closing price of $19.34.

How does Cellebrite DI stock forecast compare to its benchmarks?

Cellebrite DI's stock forecast shows a 3.41% upside, underperforming the average forecast for the technology stocks sector (33.74%).

What is the breakdown of analyst ratings for Cellebrite DI over the past three months?

  • April 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Cellebrite DI’s EPS forecast?

Cellebrite DI's average annual EPS forecast for its fiscal year ending in December 2024 is $-1.37, marking a 218.60% increase from the reported $-0.43 in 2023. Estimates for the following years are $0.26 in 2025, $0.34 in 2026, $0.62 in 2027, and $0.72 in 2028.

What is Cellebrite DI’s revenue forecast?

Cellebrite DI's average annual revenue forecast for its fiscal year ending in December 2024 is $399.39M, reflecting a 22.85% increase from the reported $325.11M in 2023. The forecast for 2025 is $465.58M, followed by $548.96M for 2026, $605.8M for 2027, and $685.5M for 2028.

What is Cellebrite DI’s net income forecast?

Cellebrite DI's net income forecast for the fiscal year ending in December 2024 stands at $-261M, representing an 221.22% increase from the reported $-81.1M in 2023. Projections indicate $48.61M in 2025, $83.6M in 2026, $118.62M in 2027, and $136.91M in 2028.